FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Amgen has finally closed its $27.8 billion takeover of Horizon Pharma, which was held up for ... its medicines with two of Horizon’s marketed products – Tepezza (teprotumumab) for thyroid ...

Auspex's lead product candidate is SD-809 ... Horizon buys Hyperion Meanwhile California-based specialist pharma company Horizon Pharma is to pay $1.1 billion for Hyperion, based in Dublin ...